PMID: 9423811Jan 10, 1998Paper

Retroviral gene transfer into cord blood stem/progenitor cells using purified vector stocks

American Journal of Hematology
J AschL M Isola

Abstract

Cord blood (CB) progenitor/stem cells (P/SC) are ideal targets for early gene therapy in individuals prenatally diagnosed with genetic disorders. Most retroviral transduction protocols were developed using adult peripheral blood stem cells (PBSC) and bone marrow (BM). Less is known about retroviral transduction of CB P/SC. We examined how timing, multiplicity of infection (MOI), and polycations in the transduction media affect transduction efficiency. Rates of transduction were determined in recently isolated CD34+ enriched CB cells and in colonies derived after various times in liquid cultures (LC). CB mononuclear cells (MNC) were separated by ficoll-hypaque centrifugation and enriched for CD34+ cells. Purity was assessed by flow cytometry. Transduction were performed with clinical-grade retroviral stocks at MOIs of 1-20. Transduction was performed with fetal bovine serum (FBS) or autologous plasma, IL-3, GM-CSF, IL-6, and SCF. The retroviral vector contained LacZ and neomycin resistance (neo) reporter genes. Transduction was determined by X-gal stain and by PCR amplification of the reporter genes. No drug selection was used. Twenty-five experiments were done. CB volumes ranged from 35-150 ml. MNC and CD34+ cell counts ranges ...Continue Reading

References

Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S PoddaA Bank
Apr 1, 1983·The Journal of Clinical Investigation·R S WeinbergB P Alter
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·M YuF Wong-Staal
Apr 1, 1995·Journal of Hematotherapy·M H QazilbashJ M Liu
Feb 1, 1995·Current Opinion in Pediatrics·D B Kohn
Jan 1, 1995·British Medical Bulletin·P M HoogerbruggeD Valerio
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·D BienzleI D Dubé

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.